Le Lézard
Classified in: Health
Subject: PDT

Rockfield Medical Devices Receives OTC Clearance for the Mobility+ Enteral Feeding System


GALWAY, Ireland, May 8, 2024 /PRNewswire/ -- Rockfield Medical Devices Limited, a commercial-stage medical device company focused on developing solutions to transform the mobility and quality of life of tube feeders, today announced U.S. Food and Drug Administration ("FDA") 510(k) Over the Counter Clearance (OTC) of the Mobility+ Enteral Feeding System.

This FDA clearance allows Rockfield Medical Devices to market the Mobility+ Enteral Feeding System for OTC use in the United States. The Company continues to deliver on its mission to transform tube feeders' mobility and quality of life. "We are excited to get OTC clearance which will allow the Company to supply the Mobility+ Enteral Feeding System without a prescription directly to the consumer (D2C) via multiple sales channels. This importantly will allow the Company to supply Mobility+ to a greater number of tube feeders in a more efficient manner in the United States. This OTC clearance combined also with the new CMS reimbursement Code of B4148 for elastomeric feeding pumps will uniquely give users greater and faster access to the Mobility+ positively transforming mobility and Quality of Life of enteral tube feeders. This is a key to what we are about as a Company, and hence our excitement to announce this positive news" said Tomás Thompson CEO of Rockfield Medical Devices.

The Mobility+ Enteral Feeding System is a portable, lightweight, elastomeric, enteral feeding system that delivers liquid nutrition formula to an enteral access device (feeding tube) in users aged two years and over, in clinical or home care settings. The System has three primary components: a food pouch, a filling set and a giving set. The Mobility+ is for single patient use and is intended for use over a 24-hour period.

Market release of Mobility+ OTC is anticipated in Q3 2024 in the United States.

About Rockfield Medical Devices Limited

Rockfield Medical Devices Limited, a company headquartered in Galway, Ireland, is a commercial-stage medical device company focused on developing solutions to transform tube feeders' mobility and quality of life. Rockfield Medical Devices is developing a portfolio of innovative feeding solutions for tube feeders. The company's first product to market is the Mobility+ Enteral Feeding System, which is now cleared by the FDA for OTC use with an Indication of Use to deliver liquid nutrition formula, to an enteral access device (feeding tube) in users aged two years and over. 

For more information on Rockfield Medical Devices visit https://rockfieldmd.com/, follow the company on LinkedIn here: https://www.linkedin.com/company/19017077/"  or email [email protected]

 

SOURCE Rockfield Medical Devices


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: